Enablers and barriers to the scaling up of pneumococcal conjugate vaccine in India during the COVID-19 pandemic: a qualitative study
R Hora, A Ray, R Mehra, T Priya… - Health services …, 2023 - journals.sagepub.com
Background: Pneumonia is one of the leading causes of death in under-5 children in India.
This led the Ministry of Health & Family Welfare (MoHFW) in India to decide for the …
This led the Ministry of Health & Family Welfare (MoHFW) in India to decide for the …
[HTML][HTML] Critical factors in the successful expansion of Pneumococcal Conjugate Vaccine in India during the COVID-19 pandemic
SS Koshal, A Ray, R Hora, A Kaur, SF Quadri, R Mehra… - Vaccine: X, 2023 - Elsevier
India had decided to roll out PCV in India in 2015, but successful implementation of any new
vaccine introduction mandates an enormous effort. PCV was scaled up during the COVID-19 …
vaccine introduction mandates an enormous effort. PCV was scaled up during the COVID-19 …
[HTML][HTML] Typhoid conjugate vaccine implementation in India: A review of supportive evidence
VV Mogasale, A Sinha, J John, HH Farooqui, A Ray… - Vaccine: X, 2024 - Elsevier
Background Typhoid conjugate vaccines are available in the private market in India and are
also recommended by the National Technical Advisory Group on Immunisation (NTAGI) for …
also recommended by the National Technical Advisory Group on Immunisation (NTAGI) for …
Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey
VV Mogasale, A Sinha, J John… - BMJ Public …, 2024 - bmjpublichealth.bmj.com
Background India has a high typhoid fever burden. In 2022, the National Technical Advisory
Group on Immunisation recommended introducing typhoid conjugate vaccine (TCV) into the …
Group on Immunisation recommended introducing typhoid conjugate vaccine (TCV) into the …
Pneumococcal serotypes causing non-invasive pneumonia in adults from a South Indian tertiary care hospital and the impact of the newer conjugate vaccines
R Varghese, BL Yesudhason… - Access …, 2021 - microbiologyresearch.org
Background. Streptococcus pneumoniae is the leading cause of community-acquired
pneumonia (CAP) in adults. Ageing, chronic conditions and comorbidities are important risk …
pneumonia (CAP) in adults. Ageing, chronic conditions and comorbidities are important risk …
Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in …
Introduction Community acquired pneumonia (CAP) is a leading cause of under-five
mortality in India and Streptococcus pneumoniae is the main bacterial pathogen for it …
mortality in India and Streptococcus pneumoniae is the main bacterial pathogen for it …
Adverse Events Following Pneumococcal Vaccination among Infants attending Immunization Clinic at a Tertiary Hospital in Northern India
Background: Pneumococcal conjugate vaccine (PCV-13) has been introduced in India in a
phased manner. In Haryana it was introduced in 2017. The adverse events following …
phased manner. In Haryana it was introduced in 2017. The adverse events following …
[引用][C] Vaccine: X
SS Koshal, A Ray, R Hora, A Kaur, SF Quadri, R Mehra… - Vaccine, 2023 - europepmc.org
abstract India had decided to roll out PCV in India in 2015, but successful implementation of
any new vaccine introduction mandates an enormous effort. PCV was scaled up during the …
any new vaccine introduction mandates an enormous effort. PCV was scaled up during the …